Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
455.3 USD | +2.77% | -0.35% | +11.91% |
May. 31 | BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480 | MT |
May. 31 | Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 456.95 | 456.95 | 456.95 |
Spread/Res. | -0.35% | -0.35% | -0.35% |
Spread/Supp. | +8.29% | +15.92% | +15.49% |
Support | 420.48 | 392.81 | 394.28 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- VRTX Stock
- Charts Vertex Pharmaceuticals Incorporated